← Leaderboards
Xiang Zhang
Sloan-Kettering Inst Can Research
$12,735,442
Attributed
$18,316,300
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,414,108 · 12
By mechanism
R01$14,304,167 · 6
P50$9,097,808 · 1
U01$2,961,230 · 1
R00$710,096 · 1
K99$169,884 · 1
F32$118,240 · 1
Top collaborators
- Stephen Tc Wong6 shared
- Yi Li5 shared
- Arun Sreekumar5 shared
- David R Rowley3 shared
- Han Xiao3 shared
- Mothaffar Fahed Rimawi1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Luis F Parada$23,930,635
- Jada Gabrielle Hamilton$5,806,920
- Craig B Thompson$56,520,903
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmNeoplasm MetastasisDesignCancer CellMetastatic Neoplasm To The BoneBoneTumorMolecularMediatingMalignant NeoplasmsPathway InteractionsPrimary NeoplasmMicrometastasisCellsBreast Cancer CellSignal TransductionOrganTherapeutic TargetBiologyNeoplastic CellBreast Cancer PatientDiagnosisResistanceSite
Grant awards (52)
Translational Research in Breast Cancer$1,230,080
P50 · FY2025 · CA · contact PI
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis$652,042
R01 · FY2025 · CA
Next Generation Rat Models of ER+ Breast Cancer$595,831
R01 · FY2025 · CA
Breast Cancer Program$52,683
P30 · FY2025 · CA · contact PI
Translational Research in Breast Cancer$1,709,045
P50 · FY2024 · CA · contact PI
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis$619,441
R01 · FY2024 · CA
Next Generation Rat Models of ER+ Breast Cancer$567,317
R01 · FY2024 · CA
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis$507,004
U01 · FY2024 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion$461,646
R01 · FY2024 · CA · contact PI
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast Cancer$361,000
R01 · FY2024 · CA · contact PI
Spatial single-cell profiling to identify tumor-immune-bone niche features in HER2-low bone metastasis in response to T-DXd treatment.$163,945
U01 · FY2024 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion$71,650
R01 · FY2024 · CA · contact PI
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis$66,138
R01 · FY2024 · CA · contact PI
Translational Research in Breast Cancer$1,974,356
P50 · FY2023 · CA · contact PI
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis$666,169
R01 · FY2023 · CA
Next Generation Rat Models of ER+ Breast Cancer$585,230
R01 · FY2023 · CA
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis$523,014
U01 · FY2023 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion$476,224
R01 · FY2023 · CA · contact PI
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression$407,228
R01 · FY2023 · CA · contact PI
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast Cancer$372,400
R01 · FY2023 · CA · contact PI
Mutating E-cadherin in rats to model lobular breast cancer$174,600
R01 · FY2023 · CA
Unveiling the mechanisms underlying secondary metastasis and possible therapeutic windows$75,421
R01 · FY2023 · CA · contact PI
Translational Research in Breast Cancer$2,091,509
P50 · FY2022 · CA · contact PI
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis$684,514
U01 · FY2022 · CA
Next Generation Rat Models of ER+ Breast Cancer$612,175
R01 · FY2022 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion$476,224
R01 · FY2022 · CA · contact PI
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression$407,228
R01 · FY2022 · CA · contact PI
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast Cancer$372,400
R01 · FY2022 · CA · contact PI
Translational Research in Breast Cancer$2,092,818
P50 · FY2021 · CA · contact PI
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis$533,688
U01 · FY2021 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion$485,943
R01 · FY2021 · CA · contact PI
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression$415,538
R01 · FY2021 · CA · contact PI
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast Cancer$380,000
R01 · FY2021 · CA · contact PI
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression$618,327
R01 · FY2020 · CA · contact PI
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis$549,065
U01 · FY2020 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion$500,945
R01 · FY2020 · CA · contact PI
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases$488,881
R01 · FY2020 · CA
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast Cancer$380,000
R01 · FY2020 · CA · contact PI
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases$474,214
R01 · FY2019 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression$427,384
R01 · FY2019 · CA · contact PI
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases$488,881
R01 · FY2018 · CA
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc$324,738
R01 · FY2018 · CA · contact PI
The role of adipocytes in melanoma$61,174
F32 · FY2018 · CA · contact PI
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc$324,738
R01 · FY2017 · CA · contact PI
The role of adipocytes in melanoma$57,066
F32 · FY2017 · CA · contact PI
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc$324,738
R01 · FY2016 · CA · contact PI
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc$324,738
R01 · FY2015 · CA · contact PI
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc$324,738
R01 · FY2014 · CA · contact PI
MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND$227,038
R00 · FY2013 · CA · contact PI
MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND$241,529
R00 · FY2012 · CA · contact PI
MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND$241,529
R00 · FY2011 · CA · contact PI
Mechanisms of Src activation and its role in latent bone metastasis of breast and$169,884
K99 · FY2010 · CA · contact PI